Verve Therapeutics, Inc.
2021 Q4 - 2025 Q2 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q2 | 8/14/2025 | 2,062 | 0.0% | 183,610 | 6/30/2025 |
| 2025 Q1 | 5/19/2025 | 610 | 0.0% | 133,566 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 676 | 0.0% | 119,818 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 557 | 0.0% | 115,041 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 529 | 0.0% | 108,446 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 619 | 0.0% | 46,592 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 649 | 0.0% | 46,592 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 618 | 0.0% | 46,592 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 325 | 0.0% | 22,515 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 325 | 0.0% | 22,515 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 413 | 0.0% | 21,355 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 945 | 0.0% | 27,502 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 229 | 0.0% | 15,000 | 6/30/2022 |
| 2021 Q4 | 2/14/2022 | 299 | 0.0% | 8,100 | 12/31/2021 |